NCT06713070
Role of Gait Analysis in Different Type of Dementia
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary endpoint(s) modified Show 8 more changesShow less
- Eligibility criteria shortened, about 6 words
- Completed without a posted recruiting period
- Primary completion date changed from estimate of May 2025 to Nov 15, 2025
- Study sites: 0 to 1
- Study completion date changed from estimate of Oct 2025 to Jan 10, 2026
- Start date changed from estimate of Dec 2024 to Dec 12, 2024
- Secondary endpoints expanded, about 21 words
- Publications: details revised at 16 of 17 entries
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Gait Speed
Timeframe: Baseline assessment.
Gait Symmetry
Timeframe: Baseline assessment.
Secondary (7)
Berg Balance Scale
Dynamic Gait Index
Timed Up and Go Test .
Timed 25-Foot Walk Test
Stride Length
Show 2 moreShow less
Cadence
Stride Duration
Arms and interventions
Cohort 1 (Dementia)
The group that will contain the diseased participants (Dementic patients able to walk and perform gait analysis)
Sites
1 site in 1 country
- Assiut University HospitalsAsyut, Assiut Governorate, Egypt